semaglutide news today october 2025 GLP-1 trends 2025: real-world data, patient outcomes & future therapies Drug compounders sue FDA over

For retailers and CPG brands, the challenge and opportunity lies in meeting these consumers precisely where they are along the weight-loss journey, engagin

Cukrzyca jest jednym z najwikszych wyzwa wspczesnej medycyny

Here's what you should know.

SEMA also reversed cerebral microcirculation effects of HFD by reducing capillary rarefaction and the interaction of leukocytes in postcapillary brain venules

New analyses involving more than 100,000 patients suggest that users of popular diabetes and weight-loss medications face a lower risk of developing certain cancers and a reduced risk of metastasis.

While telehealth can increase patient access to medications, it is critical to ensure that prescribing practices adhere to accepted standards outlined in clinical practice guidelines